|
| 37034666 | Insulinotropic effect of endogenous incretins is greater after gastric bypass than sleeve gastrectomy despite diminished beta-cell sensitivity to plasma incretins. | | 2023 |
| 36204991 | Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes. | Diabetes, Obesity and Metabolism | 2023 |
| 37853989 | Differential effect of gastric bypass versus sleeve gastrectomy on insulinotropic action of endogenous incretins. | | 2023 |
| 37790563 | Contribution of endogenous glucagon-like peptide 1 to prandial counterregulatory responses to hypoglycemia after bariatric surgery. | | 2023 |
| 37961500 | GLP-1 enhances beta-cell response to protein ingestion and bariatric surgery amplifies it. | | 2023 |
| 37467435 | Bariatric Surgery Alters the Postprandial Recovery From Hypoglycemia, Mediated by Cholinergic Signal. | | 2023 |
| 36947093 | Fasting Hyperinsulinemia and Obesity: Cause or Effect. | | 2023 |
| 36746320 | Chronic physiologic hyperglycemia impairs insulin-mediated suppression of plasma glucagon concentration in healthy humans. | | 2023 |
| 36857415 | Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients. | Diabetes Care | 2023 |
| 36988137 | Plasma insulin is required for the increase in plasma angiopoietin-like protein 8 in response to nutrient ingestion. | Diabetes Metab Res Rev | 2023 |
| 36669322 | Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases. | J Diabetes Complications | 2023 |
| 37481263 | Emergence of a New Gluco-Regulatory Mechanism for Glycemic Control with Dapagliflozin/Exenatide Therapy in Type 2 Diabetes. | | 2023 |
| 35066003 | Insulin: The master regulator of glucose metabolism. | Metabolism: Clinical and Experimental | 2022 |
| 35971756 | Are angiotensin-converting enzyme inhibitors/angiotensin receptor blockers associated with reduced severe acute respiratory syndrome coronavirus 2 infections and improved outcomes, and does race matter? | Diabetes, Obesity and Metabolism | 2022 |
| 35390439 | Prandial hepatic glucose production during hypoglycemia is altered after gastric bypass surgery and sleeve gastrectomy. | Metabolism: Clinical and Experimental | 2022 |
| 35963508 | American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. | Endocr Pract | 2022 |
| 35581905 | Type 2 diabetes subgroups and response to glucose-lowering therapy: Results from the EDICT and Qatar studies. | Diabetes, Obesity and Metabolism | 2022 |
| 35887007 | Altered Insulin Clearance after Gastric Bypass and Sleeve Gastrectomy in the Fasting and Prandial Conditions. | International Journal of Molecular Sciences | 2022 |
| 36012132 | Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects. | International Journal of Molecular Sciences | 2022 |
| 35552423 | Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects. | Journal of Clinical Endocrinology and Metabolism | 2022 |
| 36204553 | Metabolic syndrome predictors of brain gray matter volume in an age-stratified community sample of 776 Mexican- American adults: Results from the genetics of brain structure image archive. | Frontiers in Aging Neuroscience | 2022 |
| 35723225 | FGF21 contributes to metabolic improvements elicited by combination therapy with exenatide and pioglitazone in patients with type 2 diabetes. | American Journal of Physiology - Endocrinology and Metabolism | 2022 |
| 35302284 | Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes. | Diabetes, Obesity and Metabolism | 2022 |
| 34922811 | DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. | J Diabetes Complications | 2022 |
| 35253334 | Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance. | Diabetes Obes Metab | 2022 |
| 35235659 | Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose. | Diabetes Care | 2022 |
| 35014145 | Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT). | Diabetes, Obesity and Metabolism | 2022 |
| 34362813 | New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms. | Diabetes Care | 2021 |
| 36654276 | Chiglitazar: a novel pan-PPAR agonist. | | 2021 |
| 33972318 | Comment on Piccinini and Bergman. The Measurement of Insulin Clearance. Diabetes Care 2020;43:2296-2302. | Diabetes Care | 2021 |
| 33910583 | From glucose lowering agents to disease/diabetes modifying drugs: a "SIMPLE" approach for the treatment of type 2 diabetes. | Cardiovascular Diabetology | 2021 |
| 33479282 | Further evidence supporting a potential role for ADH1B in obesity. | Sci Rep | 2021 |
| 33852204 | Insulin secretion is a strong predictor for need of insulin therapy in patients with new-onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT study. | Diabetes, Obesity and Metabolism | 2021 |
| 33741697 | Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. | Diabetes Care | 2021 |
| 34162682 | Adiponectin Alleviates Diet-Induced Inflammation in the Liver by Suppressing MCP-1 Expression and Macrophage Infiltration. | Diabetes | 2021 |
| 34002953 | Insulin resistance limits corneal nerve regeneration in patients with typeâ¿¿2 diabetes undergoing intensive glycemic control. | Journal of Diabetes Investigation | 2021 |
| 33524152 | Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function. | Journal of Clinical Endocrinology and Metabolism | 2021 |
| 33522574 | Insulin Resistance and Hyperinsulinemia: the Egg and the Chicken. | Journal of Clinical Endocrinology and Metabolism | 2021 |
| 33931489 | Erratum. Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. Diabetes Care 2021;44:1062-1069. | Diabetes Care | 2021 |
| 33714226 | Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control. | Journal of Diabetes Investigation | 2021 |
| 33441626 | Serum carotenoids and Pediatric Metabolic Index predict insulin sensitivity in Mexican American children. | Scientific Reports | 2021 |
| 34343296 | Insulin Secretion Predicts the Response to Antidiabetic Therapy in Patients With New-onset Diabetes. | Journal of Clinical Endocrinology and Metabolism | 2021 |
| 34185956 | Ultrasound-Targeted Microbubble Destruction Mediates Gene Transfection for Beta-Cell Regeneration and Glucose Regulation. | Small | 2021 |
| 33547417 | Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. | Nature Reviews Nephrology | 2021 |
| 33033064 | Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects. | | 2021 |
| 33137378 | Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes. | Metabolism: Clinical and Experimental | 2021 |
| 33077684 | Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance. | | 2021 |
| 33334808 | Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort. | Diabetes Care | 2021 |
| 33273042 | Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT. | Diabetes Care | 2021 |
| 33400689 | Proximal tubular epithelial insulin receptor mediates high-fat diet-induced kidney injury. | JCI Insight | 2021 |